V8 Peptides — Engineered Performance
Research Library
What Is 5-Amino-1MQ? A Plain-Language Research Explainer
5-Amino-1MQExplainerResearch Compounds

What Is 5-Amino-1MQ? A Plain-Language Research Explainer

V8 Peptides Research TeamNovember 16, 2026

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer: 5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). It is not a peptide. It was described as a membrane-permeable NNMT inhibitor by Neelakantan and colleagues in 2018 and is studied in enzyme assays, cell culture and rodent models of the NAD+ and SAM pathways. It is a laboratory research compound only. This explainer covers the name, the target enzyme, the published work, the pathway background, and what to check on a certificate of analysis.

Where the name 5-Amino-1MQ comes from

The label is a shorthand for the chemical name. “1MQ” means 1-methylquinolinium, a quinoline ring in which the nitrogen carries a methyl group and a positive charge. The “5-Amino” prefix places an amino group on carbon 5 of that ring. So 5-Amino-1MQ is 5-amino-1-methylquinolinium.

This naming matters because the compound often appears next to peptides in catalogs and forum posts. It is not one. There is no chain of amino acids, no sequence to write and no peptide bond. It is a small organic cation, and in supplied form it is typically a salt. The cation alone has a molar mass of about 159, far below the several-kilodalton range of most research peptides. If you want to see what a real peptide structure looks like by comparison, read what are research peptides.

The target: nicotinamide N-methyltransferase

NNMT is a cytosolic enzyme that moves a methyl group from S-adenosylmethionine (SAM), the cell’s main methyl donor, onto nicotinamide. The products are 1-methylnicotinamide (often abbreviated MNA or 1-MNA) and S-adenosylhomocysteine (SAH). Because nicotinamide is also the starting material of the NAD+ salvage route, NNMT sits at a junction between two networks: NAD+ metabolism and methyl-group supply.

Work from several laboratories, including Ulanovskaya and colleagues, framed NNMT as a “methylation sink,” an enzyme that can pull methyl units away from other methylation reactions and change the methylation state of histones in cell models. Pissios and Roberti and coworkers reviewed the enzyme’s wider biology. These are mechanistic cell and rodent findings, and they explain why a selective chemical probe for NNMT is useful.

What Neelakantan and colleagues reported

In 2018, Neelakantan et al. described a series of small molecules built on the quinolinium scaffold that inhibit NNMT. A key challenge they addressed was permeability. Earlier analogs of nicotinamide were active against purified enzyme but did not cross the cell membrane well. The 5-amino-1-methylquinolinium compound was reported to be membrane-permeable, to inhibit the enzyme with low micromolar potency in biochemical assays, and to lower intracellular 1-methylnicotinamide in cultured cells. The authors also reported changes in intracellular NAD+ and SAM-related readouts consistent with reduced NNMT activity, and they carried the work into a rodent model.

A follow-up paper in 2019 from the same group used a related NNMT inhibitor in aged mouse skeletal muscle preparations and stem-cell assays. Both papers are listed in the references. They are the primary sources for the compound, and independent replication outside a small number of groups is still limited, so read the originals.

The NAD+ and SAM pathways in plain terms

NAD+ is a coenzyme used in redox reactions and as a substrate for sirtuins and PARPs. Cells make and recycle it partly through a salvage route that starts with nicotinamide. Separately, SAM donates methyl groups and becomes SAH after doing so. NNMT consumes one molecule of each, nicotinamide and SAM, in a single reaction.

That is why inhibitor experiments commonly read out MNA, SAM, SAH and NAD+ levels together. For background on the coenzyme itself, see what is NAD and NAD versus NMN versus NR. Laboratories studying salvage-pathway biochemistry also work with the coenzyme directly, and V8 lists NAD+ 1000 mg for laboratory research use.

Compared with other research compounds

The table lists descriptors only.

CompoundClassPrimary target or roleTypical research context
5-Amino-1MQSmall molecule (quinolinium cation)NNMT enzyme inhibitionCell-based and rodent-model NAD+/SAM pathway studies
NAD+Dinucleotide coenzymeRedox cofactor, sirtuin and PARP substrateSalvage-pathway and enzymology assays
NMNNucleotide precursorNAD+ salvage intermediatePrecursor-flux experiments in cells
MOTS-cPeptide (16 residues)Mitochondrial-derived signaling peptideAMPK-related cell models; see what is MOTS-c

Handling a small-molecule research powder

Small molecules do not follow peptide rules exactly, since there are no peptide bonds to hydrolyze, but common sense still applies: keep the sealed vial cold, dry and away from light, avoid repeated warming and cooling, and note the first-opened date. Always read the supplier note for the salt form because the counter-ion changes the mass of powder per mole of active cation. For solution planning use the calculator rather than rough estimates, and see storing research peptides for the general approach to vial care.

What to check on a 5-Amino-1MQ certificate of analysis

Because this is a small molecule, a report should look different from a peptide report.

HPLC purity with the chromatogram, including the integration of minor peaks. Understanding HPLC purity explains the numbers.

Identity confirmation. Ask what method confirms the structure, and whether the stated mass refers to the cation or the full salt. HPLC versus mass spectrometry describes how methods differ.

Salt form and counter-ion stated clearly.

Lot reference, date and laboratory name that match the vial.

For a walkthrough, see how to read a COA. V8 Peptides sells its products for laboratory research use only and publishes certificates of analysis for tested lots on the COA page. 5-Amino-1MQ, a 50 mg research vial, is coming soon to the V8 catalog at /products/5-amino-1mq.

Common misunderstandings

“5-Amino-1MQ is a peptide.” It is a small-molecule enzyme inhibitor.

“Cell results mean the same in an organism.” They do not automatically, and this article makes no such claim.

“NNMT only matters for NAD+.” It also draws on the SAM methyl pool, which is why both pathways are measured.

Frequently asked questions

What is 5-Amino-1MQ?

5-amino-1-methylquinolinium, a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). It is not a peptide.

Is 5-Amino-1MQ a peptide?

No. It has no amino acid backbone. It is a quinolinium ring compound with a molar mass of roughly 159 for the cation, which is why peptide terms such as sequence or residues do not apply.

What does NNMT do?

NNMT transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide and S-adenosylhomocysteine.

Why is NNMT of interest in research?

Because it links the NAD+ salvage pathway to the methyl-donor pool, so it is used as a model for how cells balance nicotinamide handling and methylation.

Who published the key 5-Amino-1MQ work?

Neelakantan and colleagues, in a 2018 Biochemical Pharmacology paper describing membrane-permeable quinolinium NNMT inhibitors.

Why does membrane permeability matter?

Earlier NNMT inhibitors were poorly cell-permeable, so they worked in enzyme assays but not in intact cells. A permeable analog allows cell-based experiments.

How does NNMT relate to NAD+?

Nicotinamide is the salvage precursor for NAD+. When NNMT consumes nicotinamide it diverts it from that route, so NNMT inhibition is used to probe NAD+ and SAM readouts in cells.

Is 5-Amino-1MQ approved in the United States?

No. V8 Peptides sells it for laboratory research use only, not for human or animal consumption.

Is 5-Amino-1MQ available now?

Check the product page for current status.

What should I check on a 5-Amino-1MQ COA?

An HPLC chromatogram, an identity method, the salt form stated, a lot reference matching the vial, a test date and a named laboratory.

References

  1. Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018;147:141-152. PMID: 29155147.
  2. Neelakantan H, Brightwell CR, Graber TG, et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem Pharmacol. 2019;163:481-492. PMID: 30753815.
  3. Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol. 2013;9(5):300-306. PMID: 23455543.
  4. Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262. PMID: 24717514.
  5. Pissios P. Nicotinamide N-methyltransferase: more than a vitamin B3 clearance enzyme. Trends Endocrinol Metab. 2017;28(5):340-353. PMID: 28291578.
  6. Roberti A, Fernandez AF, Fraga MF. Nicotinamide N-methyltransferase: at the crossroads between cellular metabolism and epigenetic regulation. Mol Metab. 2021;45:101165. PMID: 33453420.

All V8 Peptides products are sold for laboratory research use only. They are not drugs, foods, or cosmetics and are not intended for human or animal consumption.

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.